Search

info:eu-repo/semantics/published

Upon activation, T cells shift towards a metabolic program characterized by increased glucose metabolism in order to sustain proliferation and effector function. Surprisingly, while resting T lymphocytes degrade glucose aerobically to CO2, proliferating T cells metabolize glucose almostentirely to lactate in the presence of oxygen through aerobic glycolysis (the Warburg effect). This metabolic switch comprises the upregulation of glycolytic enzymes and glucose transporters to the cell membrane, leading to an increase of glycolytic flux and the concomitant production of lactate. Despite many decades of research, we still do not fully understand the mechanisms that make proliferating T cells choose glycolysis rather than oxidation of glucose to produce energy. Since activated T lymphocytes depend on a glycolytic metabolism, they must release lactate, which inthese cells is facilitated by the proton-linked monocarboxylate transporter MCT1. The transporter is part of a protein family of 14 members among which MCT1–4 facilitate the passive transmembrane transport of monocarboxylates such as lactate, pyruvate and ketone bodies. The observation that pharmacological MCT1 inhibition has shown anti-proliferative effect on T cells suggests that lactate transport is essential to T cell expansion triggered after antigen recognition. The aim of our research is to investigate the importance of MCT1-dependent regulation in T cellmetabolism. Following TCR stimulation, MCT1 was expressed early in T cells unlike MCT4 whose significant expression was detected at later time point. To investigate the role played by MCT1 in the early steps of T cell activation, we generated a transgenic mouse model where conditional deletion of the MCT1 gene was achieved specifically in T cells. Phenotype and T cell distribution in thymus and peripheral organs were normal in MCT1fl/fl CD4Cre mice. However, lack of MCT1 expression decreased the proliferative capacity of in vitro activated CD4+ or CD8+ T ce, Doctorat en Sciences biomédicales et pharmaceutiques (Médecine), info:eu-repo/semantics/nonPublished

Energy metabolism is essential for T cell function. However, how persistent antigenic stimulation affects T cell metabolism is unknown. Here, we report that long-term in vivo antigenic exposure induced a specific deficit in numerous metabolic enzymes. Accordingly, T cells exhibited low basal glycolytic flux and limited respiratory capacity. Strikingly, blockade of inhibitory receptor PD-1 stimulated the production of IFNγ in chronic T cells, but failed to shift their metabolism towards aerobic glycolysis, as observed in effector T cells. Instead, chronic T cells appeared to rely on oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO) to produce ATP for IFNγ synthesis. Check-point blockade, however, increased mitochondrial production of superoxide and reduced viability and effector function. Thus, in the absence of a glycolytic switch, PD-1-mediated inhibition appears essential for limiting oxidative metabolism linked to effector function in chronic T cells, thereby promoting survival and functional fitness., SCOPUS: ar.j, info:eu-repo/semantics/published

T-cell metabolism is central to the shaping of a successful immune response. However, there are pathological situations where T cells are rendered dysfunctional and incapable of eliminating infected or transformed cells. Here, we review the current knowledge on T-cell metabolism and how persistent antigenic stimulation, in the form of cancer and chronic viral infection, modifies both metabolic and functional pathways in T cells. This article is protected by copyright. All rights reserved., FLWIN, SCOPUS: ar.j, info:eu-repo/semantics/published